Shares of Nektar Therapeutics (NASDAQ:NKTR) added ~9% in the premarket on Friday after Oppenheimer upgraded the biopharma to ...
Oppenheimer upgraded Nektar (NKTR) to Outperform from Perform with a $6 price target The firm is refreshing its model ahead of the company’s ...
Following the shock news that Amazon has taken full creative control over James Bond, with long-term 007 producers Barbara ...
The stock of AppLovin (APP) is down nearly 30% over the past week after multiple short sellers accused the mobile technology company of ...
Shogun star Cosmo Jarvis has joined the cast of Christopher Nolan's The Odyssey - and I don't think the cast list is ever ...
Oppenheimer's Annual Healthcare Life Sciences ... Annovis is dedicated to addressing neurodegeneration in diseases such as AD and PD. The Company is committed to developing innovative therapies ...
Oppenheimer Europe (Oppenheimer) - a subsidiary of Oppenheimer Holdings, the leading investment bank and wealth manager (NYSE: OPY) - announced today a ...
NEW YORK, Feb. 27, 2025 /PRNewswire/ -- Oppenheimer Holdings Inc. today announced that Albert G. Lowenthal, Chairman of the Board of Directors and Chief Executive Officer (CEO), would step down as ...